The company is a high-tech enterprise of non-invasive neuromodulation medical devices, the company adheres to independent research and development and technology PR, the main business for clinical neurodiagnostics, brain disease diagnosis and rehabilitation, non-invasive neuromodulation, cognitive neuroscience research, AI brain control and other major segments of the market, to provide for the cerebral degenerative diseases, Parkinson's disease, depression, addiction, rehabilitation after stroke and other refractory brain diseases full line of diagnostic and therapeutic Our main customers are domestic medical institutions, colleges and universities, scientific research institutions and other enterprises and institutions.
In recent years, the government encourages the localization of medical equipment and tries to change the status quo of relying on imports of high-end medical equipment. HANXIANG Group's independently researched and developed and produced TMS transcranial magnetic stimulation system has been strategically cooperated with the Sixth Hospital of Peking University, Shanghai Mental Health Center, West China Hospital of Sichuan Province, People's Liberation Army Army General Hospital, Shenzhen People's Hospital and so on, and has been actively involved in national industry standards and clinical application, and also actively participated in national industry standards and clinical application. Application, actively participate in the national industry standards and clinical standardization promotion work greatly, and has been continuously sold to the United States, Germany, Sweden, Italy, Australia, South Korea, India, Pakistan, Algeria, Estonia and other countries."